A Phase II Study of Combination of Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma.
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary) ; Doxorubicin liposomal (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 06 Feb 2012 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 06 Feb 2012 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 06 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.